Xiaoling Su

847 total citations
41 papers, 585 citations indexed

About

Xiaoling Su is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Xiaoling Su has authored 41 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Xiaoling Su's work include Metabolomics and Mass Spectrometry Studies (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Diet and metabolism studies (6 papers). Xiaoling Su is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Diet and metabolism studies (6 papers). Xiaoling Su collaborates with scholars based in China, Canada and United States. Xiaoling Su's co-authors include Deying Chen, Lanjuan Li, Liang Li, Zeyu Sun, Yingfeng Lu, Nan Wang, Wei Xu, Tao Huan, Chong Shen and Jing Jiang and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Xiaoling Su

37 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Su China 16 354 87 84 69 56 41 585
Ruth Singleton Canada 5 460 1.3× 92 1.1× 70 0.8× 44 0.6× 46 0.8× 6 623
Puteri Shafinaz Abdul‐Rahman Malaysia 15 266 0.8× 45 0.5× 48 0.6× 81 1.2× 58 1.0× 50 635
Shelley A. Deeke Canada 10 767 2.2× 108 1.2× 83 1.0× 145 2.1× 76 1.4× 13 1.0k
Sergio Triana Germany 9 300 0.8× 263 3.0× 147 1.8× 102 1.5× 43 0.8× 15 737
Giuseppe Infusini Australia 17 394 1.1× 39 0.4× 61 0.7× 213 3.1× 32 0.6× 24 770
Akiko Okayama Japan 13 228 0.6× 45 0.5× 53 0.6× 50 0.7× 90 1.6× 30 423
Ella Cederlund Sweden 19 491 1.4× 50 0.6× 64 0.8× 46 0.7× 25 0.4× 36 940
Mark J. Sartain United States 9 308 0.9× 164 1.9× 156 1.9× 90 1.3× 18 0.3× 10 538
Min Ji Seo South Korea 18 233 0.7× 45 0.5× 95 1.1× 19 0.3× 40 0.7× 33 679
Yu-Jen Jou Taiwan 9 178 0.5× 139 1.6× 23 0.3× 53 0.8× 40 0.7× 9 497

Countries citing papers authored by Xiaoling Su

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Su more than expected).

Fields of papers citing papers by Xiaoling Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Su. The network helps show where Xiaoling Su may publish in the future.

Co-authorship network of co-authors of Xiaoling Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Su. A scholar is included among the top collaborators of Xiaoling Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Su. Xiaoling Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yiman, Xiaoling Su, Yifei Wang, et al.. (2025). Emerging tick-borne diseases in mainland China over the past decade: a systematic review and mapping analysis. The Lancet Regional Health - Western Pacific. 59. 101599–101599. 1 indexed citations
2.
Wang, Lianbang, et al.. (2025). Flavonoids as modulators of gut-liver axis: emerging therapeutic strategies for MAFLD. Frontiers in Pharmacology. 16. 1657751–1657751.
3.
Huang, Mingzhu, Tingting Cui, Siyi Liu, et al.. (2024). Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity. Journal of Medical Virology. 96(3). e29544–e29544.
4.
Zhang, Mingzhu, Run‐Ze Ye, Xiaoming Cui, et al.. (2024). A series of patients infected with the emerging tick-borne Yezo virus in China: an active surveillance and genomic analysis. The Lancet Infectious Diseases. 25(4). 390–398. 11 indexed citations
5.
6.
Cui, Tingting, Xiaoling Su, Jing Sun, et al.. (2023). Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting. EBioMedicine. 99. 104903–104903. 4 indexed citations
7.
Wang, Jingyun, et al.. (2023). Unveiling the stealthy tactics: mycoplasma’s immune evasion strategies. Frontiers in Cellular and Infection Microbiology. 13. 1247182–1247182. 9 indexed citations
8.
Sun, Zeyu, Yu Wang, Xiaoling Su, Xue Yang, & Qixia Luo. (2023). Proteomic Characterization of Human Gut Habitual Bacteroides intestinalis against Common Intestinal Bile Acid Stress. 2023. 1–10. 7 indexed citations
9.
Wang, Zhongfang, Xiaoyun Yang, Yumin Zhou, et al.. (2022). SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies. Signal Transduction and Targeted Therapy. 7(1). 132–132. 19 indexed citations
10.
Lü, Xue, Ting Wang, Zeyu Sun, et al.. (2022). Ultrastructural and proteomic profiling of mitochondria-associated endoplasmic reticulum membranes reveal aging signatures in striated muscle. Cell Death and Disease. 13(4). 296–296. 36 indexed citations
11.
Li, Yuyu, Zeyu Sun, Lan Gong, et al.. (2022). LncNSPL facilitates influenza A viral immune escape by restricting TRIM25-mediated K63-linked RIG-I ubiquitination. iScience. 25(7). 104607–104607. 16 indexed citations
12.
Deng, Zhongliang, Haiyang Hu, Danling Tang, et al.. (2022). Ultrasensitive, Specific, and Rapid Detection of Mycoplasma pneumoniae Using the ERA/CRISPR–Cas12a Dual System. Frontiers in Microbiology. 13. 811768–811768. 17 indexed citations
14.
Wang, Pengyan, Can Yue, Kefang Liu, et al.. (2021). Peptide Presentations of Marsupial MHC Class I Visualize Immune Features of Lower Mammals Paralleled with Bats. The Journal of Immunology. 207(8). 2167–2178. 5 indexed citations
15.
Su, Xiaoling, Deying Chen, Liang Li, & Lanjuan Li. (2021). High-coverage quantitative liver metabolomics using perfused and non-perfused liver tissues. Analytica Chimica Acta. 1153. 338300–338300. 2 indexed citations
16.
Lu, Yingfeng, Yan Ren, Jiangshan Lian, et al.. (2021). Dynamic metabolic profiles for HBeAg seroconversion in chronic hepatitis B (CHB) patients by gas chromatography-mass spectrometry (GC-MS). Journal of Pharmaceutical and Biomedical Analysis. 206. 114349–114349. 1 indexed citations
17.
Su, Xiaoling, et al.. (2021). Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae. Frontiers in Microbiology. 12. 766591–766591. 14 indexed citations
18.
Tian, Yinping, Qiang Zhu, Zeyu Sun, et al.. (2021). One‐Step Enzymatic Labeling Reveals a Critical Role of O‐GlcNAcylation in Cell‐Cycle Progression and DNA Damage Response. Angewandte Chemie International Edition. 60(50). 26128–26135. 33 indexed citations
19.
Chen, Deying, Xiaoling Su, Nan Wang, et al.. (2017). Chemical Isotope Labeling LC-MS for Monitoring Disease Progression and Treatment in Animal Models: Plasma Metabolomics Study of Osteoarthritis Rat Model. Scientific Reports. 7(1). 40543–40543. 21 indexed citations
20.
Shen, Chong, Zeyu Sun, Deying Chen, et al.. (2015). Developing Urinary Metabolomic Signatures as Early Bladder Cancer Diagnostic Markers. OMICS A Journal of Integrative Biology. 19(1). 1–11. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026